Signet Investment Advisory Group, Inc. Abb Vie Inc. Transaction History

Signet Investment Advisory Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $202,989 - $258,066	-1,475 Closed	0 $0
Q4 2021 Jan 27, 2022	BUY	$107.43 - $135.93 $158,459 - $200,496	1,475 New	1,475 $200,000
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $150,892 - $166,114	-1,475 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $118,722 - $160,288	1,475 New	1,475 $158,000
Q1 2019 May 06, 2019	SELL	$77.14 - $90.79 $52,069 - $61,283	-675 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$77.85 - $96.01 $52,548 - $64,806	675 New	675 $62,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Signet Investment Advisory Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Signet Investment Advisory Group, Inc. with notifications on news.